Regenerex Pharma (RGPX) Accounts Payables (2010 - 2025)
Regenerex Pharma (RGPX) reported Accounts Payables of $218748.0 for Q3 2025, up 41.48% year-over-year from $154616.0 in Q3 2024, and up 27.72% on a QoQ basis from $171268.0 in Q2 2025.
Regenerex Pharma (RGPX) has 14 years of Accounts Payables data on file, last reported at $218748.0 in Q3 2025.
- Quarterly Accounts Payables rose 41.48% year-over-year to $218748.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $218748.0 (up 41.48% YoY) and the FY2025 annual result came in at $197673.0, up 69.3% from the prior year.
- Accounts Payables advanced to $218748.0 in Q3 2025 per RGPX's latest filing, from $171268.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $218748.0 in Q3 2025 and bottomed at $47813.0 in Q4 2021.
- The 5-year median for Accounts Payables is $78950.0 (2023), against an average of $105062.3.
- The widest annual swing landed in 2021, when Accounts Payables dropped 18.52%; it then jumped 133.92% in 2024.
- Tracing RGPX's Accounts Payables over 5 years: stood at $47813.0 in 2021, then surged by 38.3% to $66125.0 in 2022, then rose by 19.4% to $78950.0 in 2023, then jumped by 133.92% to $184681.0 in 2024, then grew by 18.45% to $218748.0 in 2025.
- Per Business Quant, the three latest RGPX Accounts Payables figures stand at $218748.0 (Q3 2025), $171268.0 (Q2 2025), and $197673.0 (Q1 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 218,748.00 |
| Jun 30, 2025 | 171,268.00 |
| Mar 31, 2025 | 197,673.00 |
| Dec 31, 2024 | 184,681.00 |
| Sep 30, 2024 | 154,616.00 |
| Jun 30, 2024 | 160,696.00 |
| Mar 31, 2024 | 116,760.00 |
| Dec 31, 2023 | 78,950.00 |
| Sep 30, 2023 | 89,840.00 |
| Jun 30, 2023 | 96,504.00 |
| Mar 31, 2023 | 75,145.00 |
| Dec 31, 2022 | 66,125.00 |
| Sep 30, 2022 | 66,191.00 |
| Jun 30, 2022 | 57,491.00 |
| Mar 31, 2022 | 63,027.00 |
| Dec 31, 2021 | 47,813.00 |
| Sep 30, 2021 | 51,633.00 |
| Jun 30, 2021 | 50,984.00 |
| Mar 21, 2021 | 48,038.00 |
| Dec 31, 2020 | 58,518.00 |
| Sep 30, 2020 | 61,057.00 |
| Jun 30, 2020 | 62,570.00 |
| Mar 31, 2020 | 51,098.00 |
| Dec 31, 2019 | 115,297.00 |
| Sep 30, 2019 | 167,574.00 |
| Jun 30, 2019 | 49,785.00 |
| Mar 31, 2019 | 38,348.00 |
| Dec 31, 2018 | 42,455.00 |
| Sep 30, 2018 | 53,454.00 |
| Jun 30, 2018 | 54,203.00 |
| Mar 31, 2018 | 37,870.00 |
| Dec 31, 2017 | 43,726.00 |
| Sep 30, 2017 | 42,230.00 |
| Jun 30, 2017 | 37,230.00 |
| Mar 31, 2017 | 37,230.00 |
| Nov 30, 2014 | 688,804.00 |
| Aug 31, 2014 | 651,968.00 |
| May 31, 2014 | 602,608.00 |
| Feb 28, 2014 | 1.83 Mn |
| Nov 30, 2013 | 1.66 Mn |
| Aug 31, 2013 | 1.42 Mn |
| May 31, 2013 | 465,000.00 |
| Feb 28, 2013 | 967,962.00 |
| Nov 30, 2012 | 730,717.00 |
| Aug 31, 2012 | 246,460.00 |
| May 31, 2012 | 266,409.00 |
| Feb 29, 2012 | 266,664.00 |
| Nov 30, 2011 | 138,910.00 |
| Aug 31, 2011 | 22,046.00 |
| Nov 30, 2010 | 13,133.00 |